Yoshida Yuko, Ajiki Tetsuo, Ueno Kimihiko, Shinozaki Kenta, Murakami Sae, Okazaki Taro, Matsumoto Taku, Matsumoto Ippei, Fukumoto Takumi, Usami Makoto, Ku Yonson
Division of Hepato-Biliary-Pancreatic Surgery, Department of Surgery, Kobe University Graduate School of Medicine, 7-5-1 Kusunoki-cho, Chuo-ku, Kobe, 650-0017, Japan.
J Gastrointest Surg. 2014 Dec;18(12):2095-104. doi: 10.1007/s11605-014-2674-2. Epub 2014 Oct 18.
Although preoperative biliary drainage in jaundiced patients is controversial, external biliary drainage (EBD) is beneficial for infection control in patients with biliary cancers. When EBD is performed, additional bile replacement (BR) has the benefit of improving impaired intestinal barrier function, but the detailed mechanism remains unknown. We examined the effect of bile replacement on immune functions over the duration of BR in jaundiced patients.
Fifteen patients were enrolled into this prospective study. BR was started soon after the total serum bilirubin concentration reached 5.0 mg/dl and was continued for 14 days. Drained bile was given two times orally (2 × 100 ml/day). Concanavalin A (Con A)- and phytohemagglutinin (PHA)-stimulated lymphocyte proliferation and serum diamine oxidase (DAO) activity were measured before starting and during BR. Twenty patients with EBD and no BR were analyzed as a control group.
Serum liver enzymes, prothrombin time-international normalized ratio (PT-INR), and responses to Con A and PHA gradually improved over the 14 days of BR, but percentages of lymphocytes and DAO levels did not. PT-INR, and Con A and PHA responses did not improve during EBD in the control group. PT-INR significantly decreased in patients with a greater fraction of their drained bile replaced.
Our results indicate that preoperative BR using as large a quantity of bile as possible is useful for improving blood coagulability and cellular immunity in patients with EBD.
尽管黄疸患者术前胆道引流存在争议,但外引流(EBD)对胆管癌患者的感染控制有益。进行EBD时,额外的胆汁补充(BR)有助于改善受损的肠道屏障功能,但其详细机制尚不清楚。我们研究了黄疸患者在BR期间胆汁补充对免疫功能的影响。
15例患者纳入这项前瞻性研究。当总血清胆红素浓度达到5.0mg/dl后不久开始BR,并持续14天。引流胆汁经口服给予两次(2×100ml/天)。在开始BR前及BR期间测量刀豆蛋白A(Con A)和植物血凝素(PHA)刺激的淋巴细胞增殖及血清二胺氧化酶(DAO)活性。分析20例接受EBD但未进行BR的患者作为对照组。
在BR的14天期间,血清肝酶、凝血酶原时间-国际标准化比值(PT-INR)以及对Con A和PHA的反应逐渐改善,但淋巴细胞百分比和DAO水平未改善。对照组在EBD期间PT-INR以及对Con A和PHA的反应未改善。引流胆汁补充比例更高的患者PT-INR显著降低。
我们的结果表明,术前尽可能大量使用胆汁进行BR有助于改善EBD患者的凝血功能和细胞免疫。